VEGFA and intrahepatic cholangiocarcinoma: 18 markers showed a statistically significant difference in expression between ICC and ECC and among these, 3 biomarkers included potential targets of therapy: EGFR, c-erbB-2 and VEGF-A (vascular endothelial growth factor-A) [216].